Previous 10 | Next 10 |
Abbot Laboratories (ABT), Penumbra (PEN), Align (ALGN), Bio-Rad (BIO), and ABIOMED (ABMD) are all steaming higher as doctor's and dentist's offices reopen. There is pent-up demand for these companies' products as people put off procedures due to the coronavirus. As the coronavirus began it...
ALAMEDA, Calif. , July 20, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2020 after market close on Monday, August 3, 2020 at 4:30 PM Eastern Time. A press release with seco...
Last week, I reminded investors "stocks don't rise or fall in a straight line, so expecting some form of mean reversion is understandable," and this week, we saw high-flying NASDAQ stocks decline and lessor-loved baskets, such as industrial goods, climb. This rotation isn't too surprising,...
Launches Indigo ® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical Officer Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announ...
Revenue clarity and accelerating growth in the middle of recession suggests top stocks deserve premium valuations, but stocks don't rise or fall in a straight line, so expecting some form of mean reversion is understandable. That said, stocks tend to climb higher and fall further than most...
The Federal Reserve's financial stress test results increase risk of credit tightening and dividend cuts, and that should make most investors uneasy about buying banks. Fiscal and monetary policy could ease the burden of rising delinquency and default rates resulting from job losses and slower...
Last week, I wrote how risk of a 5% pullback was rising, and this week, uncertainty remains high enough to suggest selling rallies in sectors with demand headwinds so that cash can be used to buy better businesses where demand tailwinds are strongest. My caution stemmed from a surge in our...
This article is part of a series that provides an ongoing analysis of the changes made to Generation Investment Management’s 13F portfolio on a quarterly basis. It is based on Al Gore’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking Al Gore’s Generat...
ALAMEDA, Calif. , May 29, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair 40th Annual Growth Stock Conference on Tuesday, June 9, 2020 . A webcast of the presentation will be avai...
Penumbra (NYSE: PEN ) has priced its public offering of 753,012 common shares at $166.00/share. More news on: Penumbra, Inc., Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 18:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...